Washington University will soon lead a clinical trial aimed at preventing people with Alzheimer’s disease from developing dementia.The international trial will involve 160 patients in the U.S., Europe, and Australia who have a very rare, inherited form of Alzheimer’s, which typically causes dementia before age 50.Washington University neurologist and study lead Dr. Randall Bateman says this is one of the first clinical trials to try to treat Alzheimer’s patients before they have any symptoms.
Researchers at Washington University School of Medicine have shown a relationship between daily sleep patterns and a protein associated with Alzheimer’s disease.
The researchers found that levels of the beta amyloid protein in spinal fluid increased during waking hours and decreased during sleep.
Wash U neurologist Randall Bateman says that pattern was strongest in young, healthy test subjects. It lessened in people over sixty, and disappeared altogether in Alzheimer’s patients.
St. Louis Public Radio is a service of the University of Missouri-St. Louis.